Hyperkeratotic flexural erythema/granular parakeratosis responding to doxycycline

Area of Science:

• Dermatology
• Skin Barrier Research
• Microbiology

Background:

• Hyperkeratotic flexural erythema (HKFE), also known as granular parakeratosis (GP), is a rare dermatosis.
• Its etiology is linked to skin barrier dysfunction, but the precise cause remains unclear.
• Current management strategies lack consensus, with varied treatment outcomes.

Purpose of the Study:

• To investigate the efficacy of oral doxycycline and topical coconut oil compound as a novel treatment for therapy-resistant HKFE.
• To explore potential therapeutic avenues for this rare skin condition.

Main Methods:

• Case study/report on patients with therapy-resistant HKFE.
• Administration of oral doxycycline in conjunction with a topical coconut oil compound.
• Monitoring of clinical response and symptom resolution.

Main Results:

• Preliminary findings suggest potential therapeutic benefit of the combined treatment approach.
• Observed improvement in hyperkeratotic and erythematous lesions in resistant cases.
• Further research is warranted to confirm efficacy and establish treatment protocols.

Conclusions:

• Oral doxycycline plus topical coconut oil compound presents a potential treatment option for recalcitrant HKFE.
• This combination may address underlying skin barrier defects contributing to the condition.
• Further clinical trials are needed to validate these findings and guide clinical practice.